As of July 31, 2012, SURGLINE INTL INC carries a market capitalization of 2.74M, placing it among publicly traded companies globally. Its enterprise value stands at 3.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.74M |
| Enterprise Value | 3.27M |
As of July 31, 2012, SURGLINE INTL INC has 5.48B shares outstanding.
| Shares Outstanding | 5.48B |
These figures are as of July 31, 2012. The price-to-sales ratio is 23.81, and the price-to-book ratio stands at -1.60.
| PS Ratio | 23.81 |
| PB Ratio | -1.60 |
| P/TBV Ratio | -1.60 |
| P/FCF Ratio | -7.54 |
| P/OCF Ratio | -7.57 |
These figures are as of July 31, 2012. The EV/Sales ratio of 28.77 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.27M versus a market cap of 2.74M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 28.77 |
As of July 31, 2012, SURGLINE INTL INC maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -24.21, indicating conservative leverage, while an interest coverage ratio of -7.53 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.06 |
| Quick Ratio | 0.05 |
| Debt / Equity | -24.21 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -7.53 |
These figures cover the twelve months ended July 31, 2012. Return on assets (ROA) is negative at -3,077.64, reflecting losses generated across the asset base. Inventory turnover of 11.32 indicates how many times SURGLINE INTL INC sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -3,077.64 |
| Inventory Turnover | 11.32 |
Over the twelve months ended July 31, 2012, SURGLINE INTL INC generated 113,620.00 in revenue and converted that into -2.74M in net income, yielding earnings per share of 0.00. EBITDA reached -2.08M, while operating income came in at -2.08M.
| Revenue | 113,620.00 |
| Gross Profit | 39,110.00 |
| Operating Income | -2.08M |
| Net Income | -2.74M |
| EBITDA | -2.08M |
| EBIT | -2.08M |
As of July 31, 2012, SURGLINE INTL INC holds 7,467.00 in cash and equivalents against 375,759.00 in total debt, resulting in a net debt position of 368,292.00. Total book value stands at -1.71M, with working capital of -1.55M providing operational flexibility.
| Cash & Cash Equivalents | 7,467.00 |
| Total Debt | 375,759.00 |
| Net Debt | 368,292.00 |
| Equity (Book Value) | -1.71M |
| Working Capital | -1.55M |
SURGLINE INTL INC produced -357,444.00 in operating cash flow over the twelve months ended July 31, 2012. After subtracting -1,425.00 in capital expenditures, free cash flow totaled -358,869.00 - equivalent to 0.00 per share.
| Operating Cash Flow | -357,444.00 |
| Capital Expenditures | -1,425.00 |
| Free Cash Flow | -358,869.00 |
Over the twelve months ended July 31, 2012, SURGLINE INTL INC posted a gross margin of 34.42, reflecting its pricing power and cost economics. The operating margin of -1,832.45 and net profit margin of -2,409.35 provide insight into operational efficiency.
| Gross Margin | 34.42 |
| Operating Margin | -1,832.45 |
| Profit Margin | -2,409.35 |
| EBITDA Margin | -1,831.83 |
These figures cover the twelve months ended July 31, 2012. Free cash flow yield is negative at -13.27: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -11.53, meaning SURGLINE INTL INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -11.53 |
| FCF Yield | -13.27 |
SURGLINE INTL INC's most recent stock split took place on May 21, 2002 with a 334:177 split ratio.
| Last Split Date | 5/21/2002 |
| Split Ratio | 334:177 |
As of July 31, 2012, SURGLINE INTL INC has an Altman Z-Score of -126.11, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -126.11 |